9-FLUORO-11-HYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))-21-((METHYLSULFONYL)OXY)PREGN-4-ENE-3,20-DIONE, (11.BETA.,16.ALPHA.)-
UNII MI094O0MOF
Substance Identification & Data
This profile provides standardized clinical and technical data for 9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-((methylsulfonyl)oxy)pregn-4-ene-3,20-dione, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MI094O0MOF.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2367-73-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H35FO8S NBYRPIGEYGUQJG-CKRYEYFDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-((methylsulfonyl)oxy)pregn-4-ene-3,20-dione, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.